Effects of triamcinolone acetonide on adult human lung fibroblasts: Decrease in proliferation, surface molecule expression and mediator release

International Archives of Allergy and Immunology

Volumn 129, Issue 2, 2002, Pages 152-159

  Oddera, S ^a   Cagnoni, F ^a   Mangraviti, S ^b   Giron Michel, J ^d   Popova, O ^c   Canonica, Giorgio Walter ^a,e  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c Aventis Pharma   (Italy)

^d INSERM   (France)

^e Dept of Internal Medicine ^*  (Italy)

Author keywords

Adhesion molecules; Collagen; Corticosteroid; Fibroblast; Fibronectin; Proinflammatory mediators

Indexed keywords

ANTIINFLAMMATORY AGENT; CANCER GROWTH FACTOR; CHEMOKINE; CYTOKINE; FIBROBLAST GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; TRIAMCINOLONE ACETONIDE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CELL SURFACE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; FETAL CALF SERUM; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG ALVEOLUS CELL; LUNG FIBROBLAST; LUNG FUNCTION; MALE; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDUCTION; SURFACE PROPERTY; TISSUE CULTURE;

CELL DIVISION; COLLAGEN; FEMALE; FIBROBLASTS; FIBRONECTINS; GLUCOCORTICOIDS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; MALE; MIDDLE AGED; TRIAMCINOLONE ACETONIDE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0036977157     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065877     Document Type: Article

References (36)

1. Hamid QA, Minshall EM: Molecular pathology of allergic disease. I. Lower airway disease. J Allergy Clin Immunol 2000;105:20-36.
2. Takafuji S, Miyakuni Y, Nakagawa T, Shoji S, Murata S, Yamamoto K, Ito K: Effects of human lung fibroblasts on eosinophil degranulation. Allergy 2000;55:1170-1178.
3. Fukuda T, Fukushima Y, Numao T, Ando N, Arima M, Nakajima H, Sagara H, Adachi T, Motojima S, Makino S: Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am J Respir Cell Mol Biol 1996;14:84-94.
4. Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF: Interferon-gamma and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblasts. Eur Respir J 1999;14:759-766.
5. Smith RS, Smith TJ, Blieden TM, Phipps RP: Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 1997;151:317-322.
6. Vignola AM, Kips J, Bousquet J: Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000;105:1041-1053.
7. Bousquet J, Vignola AM, Chanez P, Campbell AM, Bonsignore G, Michel FB: Airways remodeling in asthma: No doubt, no more? Int Arch Allergy Immunol 1995;107:211-214.
8. Belvisi MG, Brown TJ, Wicks S, Foster ML: New glucocorticosteroids with an improved therapeutic ratio? Pulm Pharmacol Ther 2001;14:221-227.
9. Wallin A, Sandstrom T, Soderberg M, Howarth P, Lundback B, Della-Cioppa G, Wilson S, Judd M, Djukanovic R, Holgate S, Lindberg A, Larssen L, Melander B: The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am J Respir Crit Care Med 1999;159:79-86.
10. Tormey VJ, Bernard S, Ivory K, Burke CM, Poulter LW: Fluticasone propionate-induced regulation of the balance within macrophage subpopulations. Clin Exp Immunol 2000;119/1:4-10.
11. Schwiebert LM, Beck LA, Stellato C, Bickel CA, Bochner BS, Schleimer RP, Schwiebert LA: Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions. J Allergy Clin Immunol 1996;97/1:143-152.
12. Robinson D, Hamid Q, Ying S, Bentley A, Assoufi B, Durham S, Kay AB: Prednisone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon gamma cytokine gene expression. Am Rev Respir Dis 1993;148:401-406.
13. Hein R, Korting HC, Mehring T: Differential effect on medium potent nonhalogenated double-ester type and conventional glucocorticoids on proliferation and chemotaxis response of fibroblasts. Skin Pharmacol 1994;7:300-306.
14. Warshamana GS, Martinez S, Lasky JA, Corti M, Brody AR: Dexamethasone activates expression of the PDGF-alpha receptor and induced lung fibroblast proliferation. Am J Physiol 1998;274:L499-L507.
15. Sue-Chu M, Karjalainen EM, Laitinen A, Larsson L, Laitinen LA, Bjermer L: Placebo-controlled study of inhaled budesonide on indices of airway inflammation in bronchoalveolar lavage fluid and bronchial biopsies in cross-country skiers. Respiration 2000;67:417-425.
16. Laitinen A, Altraja A, Kämpe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997;156:951-958.
17. Findlay S, Huber F, Garcia J: Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann Allergy 1992;68:228-232.
18. Johnson M: Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol 1998;101:S434-S439.
19. Atsuta J, Plitt J, Bochner BS, Schleimer RP: Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. Am J Respir Cell Mol Biol 1999;20:643-650.
20. Wangoo A, Laban C, Cook HT, Glenville B, Shaw RJ: Interleukin-10- and corticosteroid-induced reduction in type I procollagen in a human ex vivo scar culture. Int J Exp Pathol 1997;78:33-41.
21. Cameron L, Hamid Q: Regulation of allergic airways inflammation by cytokines and glucocorticoids. Curr Allergy Asthma Rep 2001;1:153-163.
22. Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF: Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts. Eur Respir J 2000;15:68-74.
23. Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF: Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax 2002;57:237-241.
24. Jeal W, Faulds D: Triamcinolone acetonide: A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis. Drugs 1997;53:257-280.
25. Clayton A, Evans RA, Pettit E, Hallett M, Williams JD, Steadman R: Cellular activation through the ligation of intercellular adhesion molecule-1. J Cell Sci 1998;111:443-453.
26. Takafuji S, Shoji S, Ito K, Yamamoto K, Nakagawa T: Eosinophils degranulation in the presence of lung fibroblasts. Int Arch Allergy Immunol 1998;117:52-54.
27. Schmitz B, Park IA, Kaufmann R, Thiele J, Fischer R: Influence of cytokine stimulation (granulocyte macrophage-colony stimulating factor, interleukin-3, and transforming growth factor beta-1) on adhesion molecule expression in normal human bone marrow fibroblasts. Acta Haematol 1995;94:173-181.
28. Richter A, Puddicombe SM, Lordan JL, Bucchieri F, Wilson SJ, Djukanovic R, Dent G, Holgate ST, Davies DE: The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 2001;25:385-391.
29. Grande JP, Melder DC, Zinsmeister AR: Modulation of collagen gene expression by cytokines: Stimulatory effect of transforming growth factor-beta1, with divergent effects of epidermal growth factor and tumor necrosis factor-alpha on collagen type I and collagen type IV. J Lab Clin Med 1997;130:476-486.
30. Eickelberg O, Kohler E, Reichenberger F, Bertschin S, Woodtli T, Erne P, Perruchoud AP, Roth M: Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol 1999;276:L814-L824.
31. Hashimoto S, Gon Y, Takeshita I, Matsumoto K, Maruoka S, Horie T: Transforming growth factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 2001;163:152-157.
32. Pache JC, Christakos PG, Gannon DE, Mitchell JJ, Low RB, Leslie KO: Myofibroblasts in diffuse alveolar damage of the lung. Mod Pathol 1998;11:1064-1070.
33. Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS: Human endothelium as a source of multifunctional cytokines: Molecular regulation and possible role in human disease. J Interferon Cytokine Res 1999;19:91-104.
34. Cavarra E, Martorana PA, Gambelli F, de Santi M, van Even P, Lungarella G: Neutrophil recruitment into the lung is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1-proteinase inhibitor-deficient mice. Lab Invest 1996;75:273-280.
35. Djukanovic R, Homeyard S, Gratziou C, Madden J, Walls A, Montefort S, Peroni D, Polosa R, Holgate S, Howarth P: The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am J Respir Crit Care Med 1997;155:826-832.
36. Stellato C, Atsuta J, Bickel CA, Schleimer RP: An in vitro comparison of commonly used topical glucocorticoid preparations. J Allergy Clin Immunol 1999;104:623-629.